ILD Screening in Rheumatic Diseases: Strategies to Consider

Two experts from Hospital for Special Surgery review the current landscape and evidence for interstitial lung disease screening in patients with connective tissue diseases.

Related Keywords

New York ,United States ,Hospital For Special Surgery ,United Kingdom ,American ,Vazquez Rodriguez ,Jessicak Gordon ,Kimberly Showalter ,Weill Cornell Medical College ,Risk Factors ,African American ,Special Surgery ,Lung Disease ,Idiopathic Inflammatory ,Curr Rheumatol Rev ,Pulmonary Function Tests ,High Rate ,False Negative Results ,Early Detection ,Scleroderma Related Interstitial Lung ,Arthritis Rheumatol ,Patients With Systemic ,Opin Rheumatol ,Forced Vital Capacity ,Lung Diffusion Cutpoints ,Associated Radiographic Interstitial Lung Disease ,Eurj Intern Med ,Respiratory Journal ,Promoter Variant ,Rheumatoid Arthritis ,Interstitial Lung ,Rheumatoid Arthritis Remains ,Pulmonary Disease ,Interstitial Lung Disease ,Systematic Review ,Cough ,Dyspnea ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Chestx Ray ,Chest Xray ,Hest Film ,Chest Radiograph ,Thoracic Radiography ,Pulmonary Function Testing ,Spirometry ,Connective Tissue Disease ,Fever ,Hyperthermia ,Heat Exhaustion ,Heat Prostration ,Smoking ,Smoker ,Systemic Sclerosis ,Diffuse Scleroderma ,A ,Scleroderma ,Crest Syndrome ,Arthritis ,Joint ,